Pharmacy Valuation Calculator
Median 10.67x EBITDA across 237 real disclosed transactions. Three-field instant range, no signup.
Value your pharmacy
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
PharmacyM&A benchmarks (current)
Median EV/EBITDA
10.67×
P25–P75: 8.1× – 14.63×
Median EV/Revenue
0.92×
P25–P75: 0.45× – 1.6×
Deal count (full sample)
237
Median deal value
$97.8M
How this calculator works
The pharmacy calculator pulls medians from 237 disclosed M&A transactions in our database, then applies adjustments specific to pharmacy businesses (margin vs the vertical median, growth trend, recurring revenue mix, owner dependency, customer concentration). Output is a tight range around the most-likely value, plus an honest per-deal error estimate based on real engine performance.
What drives premium multiples in pharmacy
- Specialty / compounding mix above 30% (PBM rate cuts hit retail not specialty)
- LTC / closed-door book or 340B participation (recurring institutional revenue)
- URAC or ACHC accreditation in place (PE platform prerequisite, not optional)
What compresses pharmacy multiples
- Pure retail / generic-substitution exposure (PBM reimbursement compression priced in)
- DIR fee exposure trending up (margin compression unfixable at single-location scale)
- Single-payer concentration above 50% (PBM contract loss = practice unviability)
More on pharmacy valuations
- Value a medical practice
- Value a dental practice
- Value a veterinary practice
- Pharmacy median multiples· real-deal benchmarks
- Recent deal: University Compounding Pharmacy· comparable transaction
- How to value a pharmacy· long-form guide
Backed by 25,592 disclosed transactions from SEC filings, EDGAR 8-K/S-4, and verified press releases · methodology